|
|
|
School
|
Status
|
Round
|
Year
|
GMAT
GRE
|
GPA
|
YOE
Years of Experiance
|
Post-MBA industry
|
Location
|
Date
|
|---|---|---|---|---|---|---|---|---|---|
| Masters in Management |
Admitted
|
R1 | 2021 | 710 GMAT Classic | 0 | United Kingdom |
12 Nov 2020 12:28 PM
|
||
| Masters in Management |
Admitted
|
R1 | 2021 | 700 GMAT Classic | India |
12 Nov 2020 11:59 AM
|
|||
| Masters in Management |
Admitted
|
R1 | 2021 | 730 GMAT Classic | United Kingdom |
12 Nov 2020 11:44 AM
|
|||
| Masters in Management |
Admitted
|
R1 | 2021 | 760 GMAT Classic | 3.4 | 0 | Consulting | United Kingdom |
12 Nov 2020 11:40 AM
|
| Masters in Management |
Admitted
|
R1 | 2021 | 750 GMAT Classic | 3.5 | 0 | Finance: Investment Banking | United States |
12 Nov 2020 10:59 AM
|
| Masters in Management |
Admitted
|
R1 | 2021 | 770 GMAT Classic | France |
12 Nov 2020 10:40 AM
|
|||
| Full Time MBA |
Denied without Interview
|
Round 1 | 2021 | 750 GMAT Classic | 4 | 4 | India |
11 Nov 2020 03:03 PM
|
|
| MIF |
Denied without Interview
|
R1 | 2021 | 720 GMAT Classic | 3.6 | 0 | Finance: Investment Banking | United States |
11 Nov 2020 10:07 AM
|
| MIF |
Interviewed
|
R1 | 2021 | 3.6 | United States |
11 Nov 2020 07:54 AM
|
|||
| MIF |
Admitted
|
R1 | 2021 | Barbados |
11 Nov 2020 06:45 AM
|
||||
| Masters in Management |
Interviewed
|
R1 | 2021 | 720 GMAT Classic | 3.8 | 0 | Consulting | India |
10 Nov 2020 04:13 AM
|
| Full Time MBA |
Denied without Interview
|
Round 1 | 2021 | 770 GMAT Classic | 5 | Consulting | India |
09 Nov 2020 07:56 AM
|
|
| Masters in Management |
Interviewed
|
R1 | 2021 | 740 GMAT Classic | 4 | 0 | Consulting | India |
02 Nov 2020 08:15 AM
|
| Full Time MBA |
Denied without Interview
|
Round 1 | 2021 | 730 GMAT Classic | 3.9 | 5 | Finance: Venture Capital | India |
19 Oct 2020 12:47 AM
|
| Full Time MBA |
Denied without Interview
|
Round 1 | 2021 | 740 GMAT Classic | 4 | 13 | Pharmaceuticals and Biotech | India |
17 Oct 2020 02:08 PM
|
| Full Time MBA |
Invited to Interview
|
Round 1 | 2021 | 760 GMAT Classic | 3.5 | 4 | Healthcare/Pharmaceuticals | India |
16 Oct 2020 11:56 PM
|
| Full Time MBA |
Denied without Interview
|
Round 1 | 2021 | 680 GMAT Classic | 5 | Consulting | China |
16 Oct 2020 07:12 PM
|
|
| Full Time MBA |
Denied without Interview
|
Round 1 | 2021 | 740 GMAT Classic | Chile |
16 Oct 2020 05:24 PM
|
|||
| Full Time MBA |
Invited to Interview
|
Round 1 | 2021 | 650 GMAT Classic 720 GMAT Classic |
3.3 | 5 | Consulting | Brazil |
16 Oct 2020 01:22 PM
|
| Full Time MBA |
Invited to Interview
|
Round 1 | 2021 | 720 GMAT Classic | 4 | Consulting | United States |
16 Oct 2020 01:14 PM
|